Hanne Bak - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Hanne Bak

Showing results (31-40 of 33) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 33 results.

Lancet (London, England)|November 26, 2015

Exploring the evidence base for national and regional policy interventions to combat resistanceOsman A Dar, Rumina Hasan, Jørgen Schlundt, et al.

Frontiers in Pharmacology|August 13, 2016

Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the FutureWinnie de Bruijn, Cristina Ibáñez, Pia Frisk, et al.

Expert Review of Clinical Pharmacology|December 10, 2014

Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?Brian Godman, Rickard E Malmström, Eduardo Diogene, et al.

Pageof 4

Search research articles

Showing results (31-40 of 33) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 33 results.

Lancet (London, England)|November 26, 2015

Exploring the evidence base for national and regional policy interventions to combat resistanceOsman A Dar, Rumina Hasan, Jørgen Schlundt, et al.

Frontiers in Pharmacology|August 13, 2016

Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the FutureWinnie de Bruijn, Cristina Ibáñez, Pia Frisk, et al.

Expert Review of Clinical Pharmacology|December 10, 2014

Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?Brian Godman, Rickard E Malmström, Eduardo Diogene, et al.

Pageof 4